leisure time -WSS

leisure time

author：entertainment 2025-10-02 17:21:43 - browse：61669

An experimental drug from Insmed Incorporated successfully reduced lung problems among patients with an airway disease in a closely watched Phase 3 trial, sending the company’s share price soaring early Tuesday.

The drug, brensocatib, reduced so-called pulmonary exacerbations by roughly 20% versus placebo in patients with bronchiectasis, hitting the trial’s primary endpoint. The trial, called the ASPEN study, tested two dosages of the drug, and the company said both significantly cut rates of pulmonary exacerbations.

Insmed shares more than doubled in pre-market trading. Analysts have forecasted that brensocatib could lead to billions of dollars in annual sales if approved.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Why you get paid to donate plasma but not blood

hotspot

WSS

Clinic falsely told dozens they had Alzheimer's, suits say

House passes resolution saying Israel isn't a 'racist or apartheid state'

UK homeowners get some respite as inflation falls by more than anticipated to a 15

Thousands protest mob assault of women who were paraded naked in remote Indian border state

FDA seeking to stop procedures at two unregulated stem cell clinics

A look at other Americans who have crossed into North Korea over the years

explore

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

hotspot

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

What Henrietta Lacks's story taught me about my role as a doctor

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

A strong 6.5

Medical records are filled with copy

Idaho college killings: Prosecutors dispute DNA could have been planted at murder scene

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Burning questions about Delta and the next phase of the Covid pandemic

As demand for Covid shots wanes, Moderna seeks its next success

Weekend shootings leave at least 6 dead, 20 others wounded in Chicago

focus

FDA seeking to stop procedures at two unregulated stem cell clinics

Novartis develops a rapidly manufactured CAR

More hospitals are billing patients as online messages surge

Why you get paid to donate plasma but not blood

PrEP can help anyone prevent HIV. Why do so few people take it?

Malaysia cuts short music fest after British band slams anti

hotspot

focus

hotspot

focus